Cartesian Therapeutics, Inc. (RNAC) SEC filings
RNAC SEC filings moved a median of -1.02% by the close. RNAC SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the RNAC overview →
74 measured RNAC SEC filing events.
Where these RNAC SEC filings landedvs 74 measured RNAC SEC filing reactions
| Middle 50% of RNAC SEC filing reactions | -4.00% to +2.73% |
|---|---|
| Median reaction (to close) | -1.02% |
| Measured reactions | 74 |
Point-in-time · zero look-ahead
Half of the 74 RNAC SEC filing events with a measured close landed between -4.00% and +2.73%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Cartesian Therapeutics, For: Sep 29 | SEC filing · Form 8-K | -0.34% | -0.55% | |
| Form 10-Q Cartesian Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +3.30% | |
| Form 8-K Cartesian Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +0.00% | +3.30% | |
| Form 8-K Cartesian Therapeutics, For: Jun 12 | SEC filing · Form 8-K | +0.10% | -4.65% | |
| Form 8-K Cartesian Therapeutics, For: Jun 09 | SEC filing · Form 8-K | +21.68% | -2.28% | |
| Form 8-K Cartesian Therapeutics, For: May 22 | SEC filing · Form 8-K | -3.01% | -6.11% | |
| Form 10-Q Cartesian Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -2.96% | |
| Form 8-K Cartesian Therapeutics, For: Apr 30 | SEC filing · Form 8-K | +0.00% | -2.96% | |
| Form S-8 Cartesian Therapeutics, | SEC filing · Form S-8 | +0.00% | -2.96% | |
| Form DEF 14A Cartesian Therapeutics, For: Dec 31 | SEC filing · Form DEF | +0.00% | -3.55% | |
| Form DEFA14A Cartesian Therapeutics, | SEC filing · Form DEFA14A | +0.00% | -3.55% | |
| Form 8-K Cartesian Therapeutics, For: Mar 26 | SEC filing · Form 8-K | +1.33% | +2.50% | |
| Form 10-K Cartesian Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +4.58% | +37.71% | |
| Form 8-K Cartesian Therapeutics, For: Mar 09 | SEC filing · Form 8-K | +4.58% | +37.71% | |
| Form 8-K Cartesian Therapeutics, For: Jan 09 | SEC filing · Form 8-K | +0.99% | +1.61% | |
| Form 8-K Cartesian Therapeutics, For: Dec 16 | SEC filing · Form 8-K | +1.21% | -2.83% | |
| Form 10-Q Cartesian Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +17.98% | +26.25% | |
| Form 8-K Cartesian Therapeutics, For: Nov 06 | SEC filing · Form 8-K | +17.98% | +26.25% | |
| Form 8-K Cartesian Therapeutics, For: Oct 29 | SEC filing · Form 8-K | +1.23% | -0.61% | |
| Form 8-K Cartesian Therapeutics, For: Oct 15 | SEC filing · Form 8-K | -0.51% | -5.69% | |
| Form 8-K Cartesian Therapeutics, For: Oct 02 | SEC filing · Form 8-K | +1.94% | +4.28% | |
| Form 10-Q Cartesian Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -7.95% | |
| Form 8-K Cartesian Therapeutics, For: Aug 07 | SEC filing · Form 8-K | +0.00% | -7.95% | |
| Form 8-K Cartesian Therapeutics, For: Jun 13 | SEC filing · Form 8-K | +0.00% | +1.18% | |
| Form 8-K Cartesian Therapeutics, For: May 30 | SEC filing · Form 8-K | +0.20% | -4.40% | |
| Form 10-Q Cartesian Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +3.80% | +1.56% | |
| Form 8-K Cartesian Therapeutics, For: May 08 | SEC filing · Form 8-K | +3.80% | +1.56% | |
| Form S-8 Cartesian Therapeutics, | SEC filing · Form S-8 | +3.80% | +1.56% | |
| Form 8-K Cartesian Therapeutics, For: Apr 29 | SEC filing · Form 8-K | -1.84% | -2.54% | |
| Form DEF 14A Cartesian Therapeutics, For: Dec 31 | SEC filing · Form DEF | -1.84% | -2.54% | |
| Form DEFA14A Cartesian Therapeutics, | SEC filing · Form DEFA14A | -1.84% | -2.54% | |
| Form 8-K Cartesian Therapeutics, For: Apr 08 | SEC filing · Form 8-K | +2.46% | -11.93% | |
| Form 10-K Cartesian Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.41% | -3.04% | |
| Form 8-K Cartesian Therapeutics, For: Mar 13 | SEC filing · Form 8-K | +0.41% | -3.04% | |
| Form 8-K Cartesian Therapeutics, For: Mar 03 | SEC filing · Form 8-K | — | -7.21% | |
| Form 8-K Cartesian Therapeutics, For: Jan 27 | SEC filing · Form 8-K | -0.52% | +1.68% | |
| Form EFFECT Cartesian Therapeutics, | SEC filing · Form EFFECT | +0.27% | -1.42% | |
| Form 8-K Cartesian Therapeutics, For: Jan 13 | SEC filing · Form 8-K | +2.42% | +10.69% | |
| Form EFFECT Cartesian Therapeutics, | SEC filing · Form EFFECT | -0.30% | +2.12% | |
| Form POS AM Cartesian Therapeutics, | SEC filing · Form POS | -0.30% | +2.12% | |
| Form S-3 Cartesian Therapeutics, | SEC filing · Form S-3 | +2.13% | +2.79% | |
| Form 8-K Cartesian Therapeutics, For: Dec 03 | SEC filing · Form 8-K | -2.63% | +1.41% | |
| Form 10-Q Cartesian Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.85% | -1.56% | |
| Form 8-K Cartesian Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +1.85% | -1.56% | |
| Form S-8 Cartesian Therapeutics, | SEC filing · Form S-8 | +1.85% | -1.56% | |
| Form EFFECT Cartesian Therapeutics, | SEC filing · Form EFFECT | -1.23% | +5.45% | |
| Form 8-K Cartesian Therapeutics, For: Sep 25 | SEC filing · Form 8-K | -1.16% | +4.33% | |
| Form 8-K Cartesian Therapeutics, For: Sep 20 | SEC filing · Form 8-K | -3.64% | -9.82% | |
| Form S-1/A Cartesian Therapeutics, | SEC filing · Form S-1 | -3.64% | -9.82% | |
| Form S-1/A Cartesian Therapeutics, | SEC filing · Form S-1 | +0.00% | +12.24% | |
| Form DEF 14A Cartesian Therapeutics, For: Sep 20 | SEC filing · Form DEF | +3.55% | +3.97% | |
| Form 10-Q Cartesian Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.53% | -14.20% | |
| Form 8-K Cartesian Therapeutics, For: Aug 08 | SEC filing · Form 8-K | -3.53% | -14.20% | |
| Form PRE 14A Cartesian Therapeutics, For: Aug 02 | SEC filing · Form PRE | -2.00% | -4.00% | |
| Form S-1 Cartesian Therapeutics, | SEC filing · Form S-1 | -2.00% | -4.00% | |
| Form D Cartesian Therapeutics, | SEC filing · Form D | +0.48% | +3.45% | |
| Form 8-K Cartesian Therapeutics, For: Jul 01 | SEC filing · Form 8-K | +3.73% | -12.24% | |
| Form 8-K Cartesian Therapeutics, For: Jun 14 | SEC filing · Form 8-K | -1.23% | -13.05% | |
| Form 8-K Cartesian Therapeutics, For: May 22 | SEC filing · Form 8-K | +7.03% | +2.87% | |
| Form 10-Q Cartesian Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.22% | +1.09% | |
| Form 8-K Cartesian Therapeutics, For: May 08 | SEC filing · Form 8-K | +0.22% | +1.09% | |
| Form DEF 14A Cartesian Therapeutics, For: Dec 31 | SEC filing · Form DEF | +0.00% | +0.24% | |
| Form DEFA14A Cartesian Therapeutics, | SEC filing · Form DEFA14A | +0.00% | +0.24% | |
| Form 8-K Cartesian Therapeutics, For: Apr 19 | SEC filing · Form 8-K | +0.00% | +2.58% | |
| Form 8-K Cartesian Therapeutics, For: Apr 08 | SEC filing · Form 8-K | +3.27% | +11.74% | |
| Form 8-K Cartesian Therapeutics, For: Mar 26 | SEC filing · Form 8-K | -6.10% | -11.15% | |
| Form 8-K Cartesian Therapeutics, For: Mar 26 | SEC filing · Form 8-K | -3.85% | -13.83% | |
| Form 8-K Cartesian Therapeutics, For: Mar 08 | SEC filing · Form 8-K | +4.89% | -1.49% | |
| Form 10-K Cartesian Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.05% | -8.49% | |
| Form 8-K Cartesian Therapeutics, For: Mar 07 | SEC filing · Form 8-K | -2.05% | -8.49% | |
| Form 8-K Cartesian Therapeutics, For: Feb 28 | SEC filing · Form 8-K | +7.56% | +1.86% | |
| Form DEF 14A Cartesian Therapeutics, For: Feb 14 | SEC filing · Form DEF | +0.69% | +4.93% | |
| Form DEFA14A Cartesian Therapeutics, | SEC filing · Form DEFA14A | +0.69% | +4.93% | |
| Form PRE 14A Cartesian Therapeutics, For: Jan 31 | SEC filing · Form PRE | -1.39% | +4.17% |
Keep exploring
More RNAC: earnings → · analyst actions → · RNAC overview →